WeVote
Log In

Bill

Bill

AB 309

Hypodermic needles and syringes.

2025-2026 Regular Session Introduced by Sade Elhawary and 7 co-sponsors

California law expands hypodermic needle and syringe distribution to increase access for harm reduction and disease prevention purposes.

Chaptered by Secretary of State - Chapter 685, Statutes of 2025.
#hypodermicneedlesandsyringes
0
WeVote Research Nonpartisan
Bill Summary · AB 309

Legislative bill overview

AB 309 modifies California's existing syringe and needle distribution regulations to expand access to hypodermic needles and syringes. The bill, now signed into law as Chapter 685 of the 2025 Statutes, adjusts provisions governing how these medical supplies can be distributed and obtained in the state.

Why is this important

Needle and syringe access policies directly affect public health outcomes related to substance use, including reducing transmission of bloodborne diseases like HIV and Hepatitis C. These policies also influence the effectiveness of harm reduction programs and healthcare equity initiatives across California.

Potential points of contention

  • Balance between harm reduction and substance use concerns: Supporters view expanded access as essential harm reduction; critics argue it may normalize or enable drug use without adequate treatment referral requirements
  • Program implementation and funding: Unclear whether local jurisdictions have sufficient resources and infrastructure to distribute supplies, or if additional state funding is required
  • Scope of distribution changes: The specific mechanisms for expanded access (retail sales, community programs, mail-in services, etc.) may face implementation challenges or disagreement about appropriateness

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.